Marcie Edmonds was tearing open a box of air-conditioner filters in her garage last June when she felt a sharp sting in her abdomen.
The 52-year-old Ahwatukee Foothills woman had never felt a scorpion sting before that day. She had no intention of seeking medical help, but within an hour of the sting, Edmonds' mild tingling sensation worsened with throat tightness, blurry vision, darting eyes and tense muscles. She could not walk and had trouble breathing.
I would have went to, as would anybody.
With the help of a friend, she called Poison Control and was advised to go to the nearest hospital that had scorpion antivenom, Chandler Regional Medical Center. At the hospital, an emergency room doctor told her about the antivenom, called Anascorp, that could quickly relieve her symptoms. Edmonds said the physician never talked with her about the cost of the drug or treatment alternatives.
Like any good car salesmen that's going to collect a commission off the sale, the DR went for the most expensive model, without telling her that there were cheaper models to consider.
Her symptoms subsided after she received two doses of the drug Anascorp through an IV, and she was discharged from the hospital in about three hours.
Weeks later, she received a bill for $83,046 from Chandler Regional Medical Center. The hospital, owned by Dignity Health, charged her $39,652 per dose of Anascorp.
It's made for $100. bucks a dose. That's a hell of a mark up.
Her insurance bill per month just got jacked up as well.
So who got all of that excessive amount of extra?
Dignity Health (lol there's definitely some irony there) and their investors.
So here's the uncouth question: How much profit, is to much profit to be considered humane, when dealing with a persons life?
And according to this woman's bill, "we" all need to demand an answer.
The Arizona Republic reported last year about the pricey markup Arizona hospitals were charging for the antivenom made in Mexico. Pharmacies in Mexico charge about $100 per dose.
After the Food and Drug Administration approved the drug
